Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and enhancing NMDA signaling (Q35836396)

From Wikidata
Jump to navigation Jump to search
scientific article published in February 2012
edit
Language Label Description Also known as
English
Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and enhancing NMDA signaling
scientific article published in February 2012

    Statements

    Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and enhancing NMDA signaling (English)
    Smita Majumder
    Antonella Caccamo
    David X Medina
    Adriana D Benavides
    Martin A Javors
    Ellen Kraig
    Randy Strong
    Salvatore Oddo
    1 February 2012
    326-335

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit